Clinical Trial Update: Methylphenidate for Attention Deficit Hyperactivity Disorder and Autism in Children [Phase 2, Phase 3]

View source ↗

Summary

Phase 2 and Phase 3 trials evaluating methylphenidate for children with autism spectrum disorder and attention-deficit/hyperactivity disorder were completed, wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder
• Autism Spectrum Disorder

Drugs mentioned

• Methylphenidate (Methylphenidate)

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Autism, Attention Deficit Disorder With Hyperactivity | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2013-05-07